AMR Stakeholder Profile
Focus area/active in: Animal Health, One Health, Diagnostics, Therapeutics
Company/Organisation type: Industry
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of pepTides and oligonucleoTides. As a full service provider Bachem offers products for clinical development and commercial applications as well as a comprehensive catalog and exclusive custom synthesis. With 50 years of experience and subsidiaries in Switzerland, the United States, the United Kingdom and Japan, Bachem is the partner of choice for the biotech and pharma industry worldwide. Bachem. Leading Partner in Tides.
Here you can see our presentation.
Here are some company brochures:
Would you like to meet Dr. Stefanie Dobitz, Bachem virtually during the AMR Conference week?
Request a quote for a custom peptide!
Cost-efficient and green manufacturing of peptides thanks to Molecular Hiving technology™
Bachem and Jitsubo CO., LTD. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s Molecular HivingTM technology. Under the License agreement, Jitsubo will develop selected manufacturing processes using their Molecular HivingTM technology and transfer these processes to Bachem. Bachem will further optimize, scale up and produce for commercial applications.
Get in touch!
Name: Dr. Stefanie Dobitz
Position: Group Leader Custom Synthesis
Please fill out the form below to get in touch with us.